MARC Record from marc_columbia

LEADER: 04328fam a2200433 a 4500
001 4055243
005 20221027025247.0
008 970429s1997 maua 001 0 eng c
010 $a 97014689
020 $a0792399544
035 $a(OCoLC)36877323
035 $a(OCoLC)ocm36877323
035 $9AML8294HS
035 $a(NNC)4055243
035 $a4055243
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRC685.I6$bA34 1997
060 10 $aW1 DE997VME 1997$aWG 300 A232 1997
082 00 $a616.1/237$221
245 00 $aAdenosine, cardioprotection, and its clinical application /$cedited by Robert M. Mentzer, Jr. [and others].
260 $aBoston :$bKluwer Academic Publishers,$c1997.
300 $axiv, 239 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDevelopments in cardiovascular medicine ;$vv. 194
500 $aIncludes index.
505 00 $g1.$tAdenosine and Cardioprotection /$rRobert M. Mentzer, Jr. and Robert Lasley --$g2.$tConcept of Cardioprotection Against Myocardial Ischemia /$rMasatsugu Hori --$g3.$tThe Late Phase of Preconditioning Against Myocardial Stunning /$rRoberto Bolli, Xian-Liang Tang and Yumin Qiu [et al.] --$g4.$tCoronary Perfusion as the Major Determinant of Myocardial Contractility in the Heart: Implication for Myocardial Hibernation /$rMasafumi Kitakaze --$g5.$tMyocardial Protection From Reperfusion Injury With Adenosine /$rJakob Vinten-Johansen and Zhi-Qing Zhao --$g6.$tProtein Kinase C - the Key-Enzyme in Ischemic Preconditioning? /$rChristof Weinbrenner and James M. Downey --$g7.$tAdenosine, Cardioprotection and Potential Mechanisms /$rRobert Lasley --$g8.$tActivation of Ecto-5'-nucleotidase Mediates Cardioprotection in Ischemic Preconditioning: Important Role of Protein Kinase C /$rMasafumi Kitakaze, Tetsuo Minamino and Koichi Node [et al.] --
505 80 $g9.$tRole of Mn-SOD Induction in the Second Window Phenomenon of Preconditioning of Ischemic Hearts /$rTsunehiko Kuzuya, Masashi Nishida and Shiro Hoshida [et al.] --$g10.$tOpioid Receptors, K[subscript ATP] Channels and Ischemic Preconditioning /$rGarrett J. Gross and Jo El Schultz --$g11.$tBradykinin and Preconditioning Against Infarction /$rTetsuji Miura, Jun Sakamoto and Takayuki Miki --$g12.$tPreconditioning in Human Muscle and Myocytes /$rCornelia S. Carr and Derek M. Yellon --$g13.$tProtein Kinase C and Adenosine Synergistically Activate ATP-Sensitive Potassium Currents: Implications for Ischemic Preconditioning /$rYongge Liu, Wei Dong Gao and Brian O'Rourke [et al.] --$g14.$tAdenosine and Myocardial Protection in Humans /$rRobert M. Mentzer, Jr. and Robert D. Lasley --$g15.$tClinical Applications of Ischemic Preconditioning /$rYochai Birnbaum and Robert A. Kloner --$g16.$tClinical Pharmacology of Preconditioning and Adenosinergic Drugs /$rHerman Van Belle --
505 80 $g17.$tClinical Application of Ischemic Preconditioning by ATP-Sensitive Potassium Channel Openers /$rNaoshi Arakawa, Motoyuki Nakamura and Ken-ichi Fukami [et al.] --$g18.$tPotassium Channel Openers and Cardiac Surgery /$rLouis P. Perrault and Philippe Menasche --$g19.$tAnti-ischemic Effects of the ATP-sensitive Potassium Channel Opener During Coronary Angioplasty /$rSatoshi Saito, Tsuneo Mizumura and Tadateru Takayama [et al.] --$g20.$tClinical Impact of Ischemic Preconditioning on Infarct Size and Coronary No-reflow Phenomenon after Successful Recanalization in the Acute Myocardial Infarction /$rKazuo Komamura, Kazuhisa Kodama and Masafumi Kitakaze [et al.].
650 0 $aMyocardial infarction$xChemoprevention.
650 0 $aReperfusion injury$xChemoprevention.
650 0 $aAdenosine$xTherapeutic use.
650 12 $aMyocardial Ischemia$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D017202Q000188
650 12 $aMyocardial Ischemia$xprevention & control.$0https://id.nlm.nih.gov/mesh/D017202Q000517
650 22 $aAdenosine$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000241Q000627
650 22 $aIschemic Preconditioning, Myocardial.$0https://id.nlm.nih.gov/mesh/D019157
700 1 $aMentzer, Robert M.$0http://id.loc.gov/authorities/names/n97801581
830 0 $aDevelopments in cardiovascular medicine ;$vv. 194.$0http://id.loc.gov/authorities/names/n42009022
852 00 $boff,hsl$hRC685.I6$iA34 1997